1. Home
  2. ALT vs BCML Comparison

ALT vs BCML Comparison

Compare ALT & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • BCML
  • Stock Information
  • Founded
  • ALT 1997
  • BCML 2004
  • Country
  • ALT United States
  • BCML United States
  • Employees
  • ALT N/A
  • BCML N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • ALT Health Care
  • BCML Finance
  • Exchange
  • ALT Nasdaq
  • BCML Nasdaq
  • Market Cap
  • ALT 348.6M
  • BCML 325.0M
  • IPO Year
  • ALT N/A
  • BCML N/A
  • Fundamental
  • Price
  • ALT $4.15
  • BCML $27.14
  • Analyst Decision
  • ALT Strong Buy
  • BCML Strong Buy
  • Analyst Count
  • ALT 7
  • BCML 1
  • Target Price
  • ALT $16.50
  • BCML $32.00
  • AVG Volume (30 Days)
  • ALT 2.8M
  • BCML 17.3K
  • Earning Date
  • ALT 11-06-2025
  • BCML 10-23-2025
  • Dividend Yield
  • ALT N/A
  • BCML 3.69%
  • EPS Growth
  • ALT N/A
  • BCML N/A
  • EPS
  • ALT N/A
  • BCML 2.10
  • Revenue
  • ALT $20,000.00
  • BCML $94,896,000.00
  • Revenue This Year
  • ALT N/A
  • BCML $2.97
  • Revenue Next Year
  • ALT N/A
  • BCML $8.09
  • P/E Ratio
  • ALT N/A
  • BCML $12.93
  • Revenue Growth
  • ALT N/A
  • BCML N/A
  • 52 Week Low
  • ALT $2.90
  • BCML $22.22
  • 52 Week High
  • ALT $11.16
  • BCML $30.96
  • Technical
  • Relative Strength Index (RSI)
  • ALT 58.45
  • BCML 38.50
  • Support Level
  • ALT $3.93
  • BCML $27.13
  • Resistance Level
  • ALT $4.15
  • BCML $28.22
  • Average True Range (ATR)
  • ALT 0.17
  • BCML 0.61
  • MACD
  • ALT 0.01
  • BCML -0.02
  • Stochastic Oscillator
  • ALT 77.42
  • BCML 7.41

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: